2.08
price up icon2.97%   0.06
 
loading
Precedente Chiudi:
$2.02
Aprire:
$2.03
Volume 24 ore:
9.85M
Relative Volume:
1.04
Capitalizzazione di mercato:
$2.05B
Reddito:
$1.31M
Utile/perdita netta:
$-597.65M
Rapporto P/E:
-2.1443
EPS:
-0.97
Flusso di cassa netto:
$-425.62M
1 W Prestazione:
+0.00%
1M Prestazione:
-14.75%
6M Prestazione:
-21.51%
1 anno Prestazione:
-58.69%
Intervallo 1D:
Value
$2.01
$2.15
Intervallo di 1 settimana:
Value
$2.00
$2.24
Portata 52W:
Value
$1.83
$5.43

Immunitybio Inc Stock (IBRX) Company Profile

Name
Nome
Immunitybio Inc
Name
Telefono
(844) 696-5235
Name
Indirizzo
3530 JOHN HOPKINS COURT, SAN DIEGO
Name
Dipendente
673
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
IBRX's Discussions on Twitter

Confronta IBRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IBRX
Immunitybio Inc
2.08 1.99B 1.31M -597.65M -425.62M -0.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.76 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
755.90 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
436.38 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
918.92 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
198.76 42.58B 447.02M -1.18B -906.14M -6.1812

Immunitybio Inc Stock (IBRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-20 Aggiornamento Piper Sandler Neutral → Overweight
2025-03-06 Iniziato H.C. Wainwright Buy
2025-01-10 Iniziato BTIG Research Buy
2023-05-12 Downgrade Piper Sandler Overweight → Neutral
2022-08-03 Iniziato Jefferies Buy

Immunitybio Inc Borsa (IBRX) Ultime notizie

pulisher
Nov 20, 2025

Can ImmunityBio Inc. (26CA) stock sustain free cash flow2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why analysts upgrade ImmunityBio Inc. stockMarket Risk Report & Consistent Income Trade Recommendations - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Intraday pattern recognizer results for ImmunityBio Inc.July 2025 Short Interest & Safe Capital Growth Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How ImmunityBio Inc. (26CA) stock responds to bond marketWeekly Profit Summary & AI Driven Stock Price Forecasts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can ImmunityBio Inc. (26CA) stock test all time highsJuly 2025 Summary & Daily Technical Stock Forecast Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

A Fresh $16 Million Bet on ImmunityBio: What Investors Should Know - AOL.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will ImmunityBio Inc. (26CA) stock extend growth storyRate Hike & Verified Chart Pattern Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Biotech Billionaire Soon-Shiong Sued Over ImmunityBio Stock Move - MSN

Nov 19, 2025
pulisher
Nov 19, 2025

A Fresh $16 Million Bet on ImmunityBio: What Investors Should Know - The Motley Fool

Nov 19, 2025
pulisher
Nov 19, 2025

Why ImmunityBio Inc. (26CA) stock is a strong analyst pickInsider Selling & Stock Portfolio Risk Management - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What dividend safety rating applies to ImmunityBio Inc. (26CA) stockMarket Trend Review & Weekly Hot Stock Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is ImmunityBio Inc. (26CA) stock a buy before earnings resultsPortfolio Update Report & Free Daily Entry Point Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

ImmunityBio: Checking The Boxes Of A True Commercial-Stage Biotech (NASDAQ:IBRX) - Seeking Alpha

Nov 19, 2025
pulisher
Nov 19, 2025

Is ImmunityBio Inc. (26CA) stock a safe buy pre earnings2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Applying big data sentiment scoring on ImmunityBio Inc.Trade Signal Summary & Safe Capital Allocation Plans - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Why ImmunityBio Inc. (26CA) stock is upgraded to buyAnalyst Upgrade & Momentum Based Trading Signals - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Editor: 【Stock Selection Techniques】 - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Will ImmunityBio Inc. (26CA) stock justify high valuation2025 Fundamental Recap & Weekly High Momentum Picks - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

How ImmunityBio Inc. (26CA) stock compares with tech leadersJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

ImmunityBio : Jefferies Global Healthcare Conference in London - MarketScreener

Nov 17, 2025
pulisher
Nov 16, 2025

Why retail investors favor ImmunityBio Inc. stockJuly 2025 Pullbacks & Free Growth Oriented Trading Recommendations - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

What drives ImmunityBio Inc 26CA stock priceStock Split Announcements & Exceptional Return Stocks - earlytimes.in

Nov 16, 2025
pulisher
Nov 16, 2025

ImmunityBio Inc. recovery potential after sell offJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Tick level data insight on ImmunityBio Inc. volatilityTrade Analysis Summary & Technical Confirmation Trade Alerts - newser.com

Nov 16, 2025

Immunitybio Inc Azioni (IBRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):